Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2005 2
2007 2
2009 3
2011 1
2014 2
2019 1
2020 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia and Hair Damage Induced by Oncological Therapy.
Jedličková H, Vokurka S, Vojtíšek R, Malečková A. Jedličková H, et al. Klin Onkol. 2019 Fall;32(5):353-359. doi: 10.14735/amko2019353. Klin Onkol. 2019. PMID: 31610668 Review. English.
Damage and loss of hair (alopecia) is a predictable adverse event of oncological therapy. It can be caused by chemotherapy, radiotherapy, or targeted and hormonal therapy. ...Targeted therapy and immunotherapy can cause immune-mediated alopecia such as alopecia areata and …
Damage and loss of hair (alopecia) is a predictable adverse event of oncological therapy. It can be caused by chemotherapy, radiother …
Hair disorders associated with autoimmune connective tissue diseases.
Cassano N, Amerio P, D'Ovidio R, Vena GA. Cassano N, et al. G Ital Dermatol Venereol. 2014 Oct;149(5):555-65. Epub 2014 Jun 30. G Ital Dermatol Venereol. 2014. PMID: 24975949 Review.
Hair disorders are frequently observed in various systemic diseases, including autoimmune connective tissue diseases (CTDs), with predilection of lupus erythematosus (LE), followed by dermatomyositis (DM) and scleroderma. ...Less common hair disorders include anagen effluv …
Hair disorders are frequently observed in various systemic diseases, including autoimmune connective tissue diseases (CTDs), with pre …
Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
Kim JS, Blizzard S, Woodward JA, Leyngold IM, Liss J, Freedman SF. Kim JS, et al. Ophthalmol Glaucoma. 2020 Jul-Aug;3(4):288-294. doi: 10.1016/j.ogla.2020.03.009. Epub 2020 Apr 3. Ophthalmol Glaucoma. 2020. PMID: 33008561
., conjunctival hyperemia, iris heterochromia, and buphthalmos), (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, eyelid erythema, eyelid edema, eyelid hyperpigmentation, high upper eyelid crease, upper eyelid ptosis, upper and/or lower eyelid retraction, …
., conjunctival hyperemia, iris heterochromia, and buphthalmos), (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, e …
Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment.
Turker S, Cilbir E, Karacin C, Altinbas M. Turker S, et al. J Cancer Res Ther. 2020 Apr-Jun;16(3):690-692. doi: 10.4103/jcrt.JCRT_343_17. J Cancer Res Ther. 2020. PMID: 32719294 Free article.
The patient noticed increase in fairy hair especially at facial area as well as in the whole body beginning after the first few cycles of treatment, after 3 months. Obvious hypertrichosis, androgenic alopecia, and trichomegaly were observed. Blood tests for androgen …
The patient noticed increase in fairy hair especially at facial area as well as in the whole body beginning after the first few cycles of tr …
Dermatological side effects of targeted antineoplastic therapies: a prospective study.
Agirgol S, Çaytemel C, Pilanci KN. Agirgol S, et al. Cutan Ocul Toxicol. 2020 Dec;39(4):380-384. doi: 10.1080/15569527.2020.1833028. Epub 2020 Oct 20. Cutan Ocul Toxicol. 2020. PMID: 33028137 Clinical Trial.
Forty-two patients were using trastuzumab (single therapy in 29 patients and combined therapy in 13 patients), five patients were using cetuximab, three patients were using sunitinib, eight patients were using panitumumab, and six patients were using pertuzumab. In 22 patients, P …
Forty-two patients were using trastuzumab (single therapy in 29 patients and combined therapy in 13 patients), five patients were using cetu …
Identification of Oliver-McFarlane syndrome caused by novel compound heterozygous variants of PNPLA6.
Liu F, Ji Y, Li G, Xu C, Sun Y. Liu F, et al. Gene. 2020 Nov 30;761:145027. doi: 10.1016/j.gene.2020.145027. Epub 2020 Aug 3. Gene. 2020. PMID: 32758583
METHODS: We collected clinical biochemical and data and brain MRI data and used whole-exon gene detection and analysis tools to evaluate the pathogenicity of the variants, including PolyPhen-2 and Mutation Taster, and we also generated three-dimensional protein structures and vis …
METHODS: We collected clinical biochemical and data and brain MRI data and used whole-exon gene detection and analysis tools to evaluate the …
The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth?
Alexandrescu DT, Kauffman CL, Dasanu CA. Alexandrescu DT, et al. Dermatol Online J. 2009 Mar 15;15(3):1. Dermatol Online J. 2009. PMID: 19379645 Free article. Review.
The effects of EGFR blockage on the hair cycle include terminal differentiation of the hair follicle, which in certain cases may be associated with trichomegaly. Trichomegaly of the eyelashes may occur as an isolated occurrence or, frequently, as part of a generaliz …
The effects of EGFR blockage on the hair cycle include terminal differentiation of the hair follicle, which in certain cases may be associat …
Comparison of hair manifestations in cardio-facio-cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth.
Urban J, Qi L, Zhao H, Rybak I, Rauen KA, Kiuru M. Urban J, et al. J Eur Acad Dermatol Venereol. 2020 Mar;34(3):601-607. doi: 10.1111/jdv.16082. Epub 2020 Jan 2. J Eur Acad Dermatol Venereol. 2020. PMID: 31736117 Free PMC article.
RESULTS: While both syndromes displayed abnormal hair, striking differences were observed, including darker and thicker scalp hair and sparse eyebrows and eyelashes in CFCS. By contrast, synophrys, trichomegaly and abnormalities of the scalp hair shafts were obse …
RESULTS: While both syndromes displayed abnormal hair, striking differences were observed, including darker and thicker scalp hair an …
Acquired trichomegaly in uveitis.
Bayer A, Bagkesen H, Sobaci G. Bayer A, et al. Can J Ophthalmol. 2007 Feb;42(1):101-6. Can J Ophthalmol. 2007. PMID: 17361249
Based on our clinical observations, we examined the relation between trichomegaly and uveitis. ...INTERPRETATION: Trichomegaly and uveitis were positively associated. Further clinical trials are needed to verify this relation and to elucidate the mechanism(s) …
Based on our clinical observations, we examined the relation between trichomegaly and uveitis. ...INTERPRETATION: Trichomeg …
Oliver McFarlane syndrome and choroidal neovascularisation: a case report.
Makuloluwa AK, Dodeja R, Georgiou M, Gonzalez-Martin J, Hagan R, Madhusudhan S, Michaelides M. Makuloluwa AK, et al. Ophthalmic Genet. 2020 Oct;41(5):451-456. doi: 10.1080/13816810.2020.1783689. Epub 2020 Jun 25. Ophthalmic Genet. 2020. PMID: 32586184
She was initially treated with a single injection of intravitreal bevacizumab and 2 years later with an injection of intravitreal ranibizumab for a recurrence. Although macular scarring secondary to the CNV was observed, her vision has stabilised and she continues to be cl …
She was initially treated with a single injection of intravitreal bevacizumab and 2 years later with an injection of intravitreal ranibizuma …
19 results